Including infrastructure and supplier costs, total capital expenditure at Chempark Dormagen amounts to more than €400 million. The site is to become Bayer MaterialScience’s European center for TDI production. Under construction for 30 months, the new plant replaces a smaller production unit for TDI. The chemical is used in the production of flexible polyurethane foams, which is used to produce many everyday articles including mattresses, car seats and upholstered furniture. Demand for TDI is expected to continue growing steadily worldwide in the years ahead.
Patrick Thomas, CEO of Bayer MaterialScience, presented the capital expenditure project within the context of the planned separation of the company from the Bayer Group. “MaterialScience is superbly positioned worldwide and optimally prepared to operate independently. Our products are in demand, our customers value our innovative power, and we are leaders in our markets,” he said.